Your browser doesn't support javascript.
loading
Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia.
Ravandi, Farhad; Ritchie, Ellen K; Sayar, Hamid; Lancet, Jeffrey E; Craig, Michael D; Vey, Norbert; Strickland, Stephen A; Schiller, Gary J; Jabbour, Elias; Pigneux, Arnaud; Horst, Heinz-August; Récher, Christian; Klimek, Virginia M; Cortes, Jorge E; Carella, Angelo-Michele; Egyed, Miklos; Krug, Utz; Fox, Judith A; Craig, Adam R; Ward, Renee; Smith, Jennifer A; Acton, Gary; Kantarjian, Hagop M; Stuart, Robert K.
Afiliação
  • Ravandi F; University of Texas MD Anderson Cancer Center, Houston, TX, USA fravandi@mdanderson.org.
  • Ritchie EK; Weill Cornell Medical Center, New York, NY, USA.
  • Sayar H; Indiana University Simon Cancer Center, Indianapolis, IN, USA.
  • Lancet JE; Moffitt Cancer Center, Tampa, FL, USA.
  • Craig MD; West Virginia University, Morgantown, WV, USA.
  • Vey N; Institut Paoli-Calmettes and Aix-Marseille University, Marseille, France.
  • Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Schiller GJ; David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
  • Jabbour E; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pigneux A; Université de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, France.
  • Horst HA; University Hospital Schleswig-Holstein, Kiel, Germany.
  • Récher C; Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse III, Centre Hospitalier Universitaire de Toulouse, France.
  • Klimek VM; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Cortes JE; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Carella AM; IRCCS AOU San Martino-IST, Genova, Italy.
  • Egyed M; Kaposi Mor Teaching Hospital, Kaposvar, Hungary.
  • Krug U; Universitätsklinikum Münster, Germany.
  • Fox JA; Sunesis Pharmaceuticals, Inc., South San Francisco, CA, USA.
  • Craig AR; Sunesis Pharmaceuticals, Inc., South San Francisco, CA, USA.
  • Ward R; Sunesis Pharmaceuticals, Inc., South San Francisco, CA, USA.
  • Smith JA; Sunesis Pharmaceuticals, Inc., South San Francisco, CA, USA.
  • Acton G; Sunesis Pharmaceuticals, Inc., South San Francisco, CA, USA.
  • Kantarjian HM; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Stuart RK; Medical University of South Carolina, Charleston, SC, USA.
Haematologica ; 103(11): e514-e518, 2018 11.
Article em En | MEDLINE | ID: mdl-29794146
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos